EcoDrugPlus

Granzyme B-Like

Ensembl ID : ENSSDUG00000004177
Gene Symbol: LOC111232190
2 Cross references
965 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSSDUG00000004161
Gene Symbol: LOC111232191
2 Cross references
965 Possible Orthologues:

Granzyme E-Like

Ensembl ID : ENSSDUG00000004155
Gene Symbol: LOC111232207
2 Cross references
965 Possible Orthologues:

Granzyme-Like Protein 2

Ensembl ID : ENSSDUG00000014568
Gene Symbol: LOC111239168
2 Cross references
965 Possible Orthologues:

Growth Hormone Secretagogue Receptor Type 1-Like

Ensembl ID : ENSSDUG00000011039
Gene Symbol: LOC111225895
3 Cross references
212 Possible Orthologues:

Growth Hormone-Releasing Hormone Receptor-Like

Ensembl ID : ENSSDUG00000007734
Gene Symbol: LOC111232200
2 Cross references
191 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSSDUG00000002951
Gene Symbol: GUCY1A1
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSSDUG00000001564
Gene Symbol: GUCY1A2
4 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSSDUG00000002920
Gene Symbol: GUCY1B1
3 Cross references
210 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSSDUG00000003810
Gene Symbol: HSP90AB1
3 Cross references
339 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha

Ensembl ID : ENSSDUG00000009687
Gene Symbol: LOC111235802
3 Cross references
345 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha 1

Ensembl ID : ENSSDUG00000009654
Gene Symbol: LOC111235810
3 Cross references
330 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).